Nan Fung Group Holdings’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Nan Fung Group Holdings’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-113,950	Closed	-$4.38M	–	43
2023 Q2	$4.38M	Hold	113,950	–	–	2.8%	9
2023 Q1	$2.64M	Hold	113,950	–	–	1.8%	12
2022 Q4	$2.99M	Hold	113,950	–	–	2.06%	9
2022 Q3	$2.24M	Buy	+113,950	New	+$2.29M	1.43%	12

Nan Fung Group Holdings's KDNY Position: Q3 2023 in Review

Nan Fung Group Holdings sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 113,950 shares — an estimated $4.38M sold.

Nan Fung Group Holdings first reported a position in KDNY in Q3 2022 and held it in 4 quarters. The position peaked at $4.38M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Nan Fung Group Holdings reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Nan Fung Group Holdings sold 113,950 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $4.38M.
Nan Fung Group Holdings first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Nan Fung Group Holdings's Chinook Therapeutics, Inc. Common Stock position peaked at $4.38M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Nan Fung Group Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.